Hemo Organic Limited (HEMORGANIC) — Share Price, Financials & Ratios

Hemo Organic Limited is seeing revenue contract sharply and has a widely-held ownership base, with promoters at just 17%. Ownership as of Jun 2026.

Market Cap

6.55 Cr

P/E Ratio

—

P/B Ratio

—

ROE

—

ROCE

—

Dividend Yield

—

52W High

₹18.91

52W Low

₹17.97

Quarterly financials

Metric	Q1 2026-27	Q4 2025-26	Q3 2025-26	Q2 2025-26
Revenue	Rs 0	92.70 L	Rs 0	Rs 1,000
Net Profit	-7.42 L	-50.57 L	-15.58 L	-3.09 L
EPS	-0.21	-1.46	-0.45	-0.09
Operating Profit	-7.42 L	-29.69 L	-4.77 L	-4.12 L

Figures in Cr (crore) unless noted. Source: NSE XBRL filings.

Promoter

16.85%

Public

83.15%

PUBLIC BREAKDOWN

Individuals

72.20%

As of 30 Jun 2026. FII, DII, MF & Individuals are sub-categories of Public.

Mutual fund holdings data for this stock hasn't been ingested yet — check back soon.

No corporate actions on record for this stock.

Full price history, technical indicators, and every field above via one REST API call.